CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Argentum Pharmaceuticals LLC et al. vs. Novartis AG

Explore the PTAB proceeding IPR2017-01063 filed by Argentum Pharmaceuticals LLC et al. on 2017-03-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-01063

Filing Date

2017-03-10

Accorded Filing Date

2017-03-10

Institution Decision Date

—

Last Modified Date

—

Proceeding Type

IPR

Termination Date

2017-09-25

Trial Status

Final Written Decision

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12094173
Respondent Patent Number 9006224
Legal Expiration Date
2028-07-01 Active (1.6 yrs remaining)
Patent Term Adjustment (PTA) +589 Days Awarded
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor Peter Wayne Marks et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Final Written Decision

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

32 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVARTIS PHARMACEUTICAL CORPORATION - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number 1095
Address 250 Massachusetts Avenue, Cambridge, MA, 02139, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
39030 Jean Silveri +1 617-871-5134
40232 Timothy Witkowski +1 617-301-1869
43228 Peter Waibel +1 862-778-7838
46473 Emily Wu +1 858-812-1539
46593 Laurie Lawrence +1 617-871-8584
48631 Carol Fang +1 650-467-2901
51681 Mark Flanigan +1 817-615-5080
53504 Daniel Raymond +1 858-812-1617

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 3 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): 🇪🇺 Europe GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2017-03-13
IPR2017-01078

West-Ward Pharmaceuticals International Limited v. Novartis AG

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-07-22
IPR2016-01479

Par Pharmaceutical, Inc. et al. v. Novartis AG

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-19
IPR2016-01461

Roxane Laboratories, Inc. et al. v. Novartis AG

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

76
12

IPR2016-01479 Final Written Decision Paper

2020-10-05 FILING PARTY: BOARD
11

Decision on Granting Motions for Joinder Paper

2017-09-25 FILING PARTY: BOARD
10

Waiver Of Patent Owner's Preliminary Response Paper

2017-06-29 FILING PARTY: PATENT OWN
9

Patent Owner's Response To Motion For Joinder Paper

2017-04-10 FILING PARTY: PATENT OWN
8

Notice of Accord Filing Date Paper

2017-03-29 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc